Whole genome re-sequencing identifies a mutation in an ABC transporter (mdr2) in a Plasmodium chabaudi clone with altered susceptibility to antifolate drugs
2011

Mutation in Plasmodium chabaudi Linked to Drug Resistance

publication Evidence: moderate

Author Information

Author(s): Martinelli Axel, Henriques Gisela, Cravo Pedro, Hunt Paul

Primary Institution: Centro de Malaria e Outras Doenças Tropicais/IHMT/UEI Biologia Molecular, Universidade Nova de Lisboa

Hypothesis

Does a mutation in the mdr2 gene affect the susceptibility of Plasmodium chabaudi to antifolate drugs?

Conclusion

The study identifies a mutation in the mdr2 gene that is linked to increased resistance to sulphadoxine in Plasmodium chabaudi.

Supporting Evidence

  • A mutation in the mdr2 gene was found to be linked to drug resistance.
  • Four point mutations were identified in the genome of the resistant clone.
  • Previous studies indicated that genetic markers on chromosome 13 are associated with drug responses.

Takeaway

Scientists found a change in a gene that helps a malaria parasite resist a type of medicine. This could help us understand how to fight malaria better.

Methodology

The researchers sequenced the genome of a drug-resistant malaria clone and compared it to a sensitive progenitor to identify mutations.

Limitations

The study primarily focuses on a single clone, which may not represent broader genetic variations in malaria.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.ijpara.2010.08.008

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication